GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity. The company offers a technology for clinical procedures and tissue fusion. The technology involves creation of endo-luminal anastomoses that bypass portions of the gastrointestinal tract, thus allowing to simplify operating procedures in the digestive system. GI Windows aims to demonstrate improved clinical outcomes and reduce healthcare costs for patients and providers.